P
Peter H. Gann
Researcher at University of Illinois at Chicago
Publications - 163
Citations - 15951
Peter H. Gann is an academic researcher from University of Illinois at Chicago. The author has contributed to research in topics: Prostate cancer & Prostate. The author has an hindex of 47, co-authored 154 publications receiving 15239 citations. Previous affiliations of Peter H. Gann include Brigham and Women's Hospital & University of Illinois at Urbana–Champaign.
Papers
More filters
Journal ArticleDOI
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
June M. Chan,Meir J. Stampfer,Edward Giovannucci,Peter H. Gann,Jing Ma,Peter Wilkinson,Charles H. Hennekens,Michael Pollak +7 more
TL;DR: A strong positive association was observed between IGF-I levels and prostate cancer risk, independent of baseline prostate-specific antigen levels, which may have implications for risk reduction and treatment.
Journal ArticleDOI
American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer with Healthy Food Choices and Physical Activity
Lawrence H. Kushi,Tim Byers,Colleen Doyle,Elisa V. Bandera,Marji McCullough,Ted Gansler,Kimberly S. Andrews,Michael J. Thun,Barbara E. Ainsworth,Rachel Ballard-Barbash,Abby F. Bloch,June M. Chan,Ralph J. Coates,Wendy Demark-Wahnefried,Jo L. Freudenheim,Peter H. Gann,Edward Giovannucci,T. J. Hartman,Laurence N. Kolonel,Alice H. Lichtenstein,Maria Elena Martinez,Anne McTiernan,Marion E. Morra,Arthur Schatzkin,Marty L. Slattery,Stephanie A. Smith-Warner,Judith Wylie-Rosett,Wei Zheng,Terri Ades,Vilma Cokkinides,Alicia Samuels,David P. Ringer,Robert A. Smith +32 more
TL;DR: This committee presents one key recommendation for community action to accompany the four recommendations for individual choices to reduce cancer risk, recognizing that a supportive social environment is indispensable if individuals at all levels of society are to have genuine opportunities to choose healthy behaviors.
Journal ArticleDOI
Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends
Ruth Etzioni,David F. Penson,Julie M. Legler,Dante di Tommaso,Rob J. de Boer,Peter H. Gann,Eric J. Feuer +6 more
TL;DR: The results suggest that the majority of screen-detected cancers diagnosed between 1988 and 1998 would have presented clinically and that only a minority of cases found at autopsy would have been detected by PSA testing.
Journal ArticleDOI
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
TL;DR: High levels of circulating testosterone and low levels of SHBG-both within normal endogenous ranges-are associated with increased risks of prostate cancer, and circulating levels of DHT and AAG do not appear to be strongly related to prostate cancer risk.
Journal ArticleDOI
A Prospective Evaluation of Plasma Prostate-Specific Antigen for Detection of Prostatic Cancer
TL;DR: A single PSA measurement had a relatively high sensitivity and specificity for detection of prostate cancers that arose within 4 years and cost and the ability of current treatments to improve the prognosis of screen-detected cases are considered.